June 4, 2019 Bio/Pharma/CRO PR/Corporate Product Launch

Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine

Basel, 04 June 2019 Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine Venclexta/Venclyxto plus Gazyva/Gazyvaro showed improvements across multiple efficacy measures compared to Gazyva/Gazyvaro plus chlorambucil, including progression-free survival and deep remissions as determined by... Read more

June 4, 2019 Bio/Pharma/CRO Chromatography Lab Top-10

Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies

Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies SANTA CLARA, Calif., June 4, 2019 Agilent Technologies Inc. (NYSE: A) announced today the results of its first Pharma Lab Leaders Survey looking to gather insights from pharmaceutical, biopharmaceutical, and contract research laboratories in seven countries around the world. Respondents included 650... Read more

May 28, 2019 Bio/Pharma/CRO Informatics & Software M&A, Partnerships Process Analytical Instr.

GE Healthcare and Rockwell Automation Collaborate to Drive the Next Generation of Bioprocessing Automation

March 28, 2019 Collaboration will help drug manufacturers improve efficiencies, get to market faster and deliver personalized medicines with innovative solutions Joint work is pivotal step in transforming biopharmaceutical manufacturing to meet the needs of the biopharma 4.0 era Chicago, IL and Milwaukee, WI, US – March 28, 2019 – GE Healthcare and Rockwell Automation are combining their... Read more

May 27, 2019 Bio/Pharma/CRO Lab Top-10 Process Analytical Instr.

MilliporeSigma Expands Cell Culture Media Production Facility in Irvine

Demonstrates MilliporeSigma’s commitment to the UK Only MilliporeSigma facility to produce both liquid and powder cell culture media Irvine, Scotland, May 27, 2019 — MilliporeSigma, a leading science and technology company, today announced the completion of a £2.7 million expansion to its Irvine biopharmaceutical production facility. The site is MilliporeSigma’s only location where both liquid and... Read more

May 16, 2019 Acad, Gov/Utilities Bio/Pharma/CRO

Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia

Basel, 16 May 2019 Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia Fixed 12-month treatment with Venclexta plus Gazyva significantly reduced risk of disease progression or death by 67% compared to a current standard-of-care Approval for expanded use of Venclexta offers more adults with chronic lymphocytic leukaemia... Read more

May 7, 2019 Bio/Pharma/CRO Licensing, IP, and Legal

A wholly-owned subsidiary, Takara Biotechnology (Dalian) Co., Ltd. Acquires ISO:13485 certification

2019/05/07 Kusatsu/Shiga, Japan – April 24, 2019 –  Takara Bio Inc. (Takara Bio) announced that Takara Biotechnology (Dalian) Co., Ltd. (Dalian city, China, hereafter “Takara Biotechnology (Dalian)”), a wholly-owned subsidiary of Takara Bio has acquired ISO 13485:2016 certification, an international standard for quality management system of medical devices and diagnostic pharmaceuticals.   Takara Biotechnology (Dalian) is a... Read more

April 30, 2019 Acad, Gov/Utilities Bio/Pharma/CRO PR/Corporate

BD Receives FDA Approval for Fully Sterile Chlorhexidine Gluconate Antiseptic Skin Preparation

FRANKLIN LAKES, N.J., April 30, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for BD ChloraPrep™ skin preparation with sterile solution, the only fully sterile chlorhexidine gluconate (CHG) antiseptic skin preparation commercially available in the... Read more

April 22, 2019 Bio/Pharma/CRO Clinical Research/Diagn. M&A, Partnerships

Elpiscience and Bio-Techne Announce Strategic Collaboration

APRIL 22, 2019 SHANGHAI and MINNEAPOLIS, April 22, 2019 /PRNewswire/ — Elpiscience BioPharma and Bio-Techne Corporation announced today that the companies have entered into a strategic collaboration for the development of anti-cancer therapeutics. Under the terms of the agreement, Elpiscience will have access to multiple antibodies from Bio-Techne’s extensive product portfolio for use in the development of preclinical, clinical, and commercial... Read more

April 17, 2019 Bio/Pharma/CRO Product Launch

Jackson ImmunoResearch launches Secondary Antibodies for VHH discovery

West Grove, PA – April 17, 2019 – Jackson ImmunoResearch, manufacturer of secondary antibodies for the life science market, announces a new range of products for scientists developing single-domain VHH antibodies.The new Anti-Alpaca secondary antibody product line targets the IgG repertoire of camelid immunoglobulins, including whole molecule, subclass and VHH domain specificities. They are raised against... Read more

April 17, 2019 Acad, Gov/Utilities Bio/Pharma/CRO Chromatography Clinical Research/Diagn. Lab Top-10 PR/Corporate

Agilent Receives an Expanded FDA Approval for its Companion Diagnostic in NSCLC

Agilent Receives an Expanded FDA Approval for its Companion Diagnostic in NSCLC PD-L1 IHC 22C3 pharmDx Can Now Be Used to Identify a Broader Range of NSCLC Patients for First-line Treatment With KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., April 16, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has... Read more